Germany: NORD Holding invests in Material Analytischer Service

NORD Holding has acquired a majority stake in Germany-based Material Analytischer Service (MAS) as part of a succession solution. With NORD Holding’s involvement, MAS,...

France: Lauxera targets final close of €500m for second fund

Healthcare focused asset manager, Lauxera Capital Partners, has closed its Growth Fund II at €400m, and is eyeing a final close of €500m by...

Switzerland: Healthcare Holding Schweiz acquires stake in Qunique

Healthcare Holding Schweiz, a provider of medical technology services and distribution solutions in Switzerland, has expanded its portfolio and strengthened its expertise in regulatory...

Switzerland: Fremman Capital acquires Stingray Healthcare to create Europe’s largest cancer care platform

Fremman Capital has acquired Stingray Healthcare, a Switzerland headquartered European cancer care platform, from Jacobs Capital. Following the transaction, Fremman will merge Stingray with...

Italy: AAVantgarde Bio closes US$141m Series B to accelerate gene therapies for Stargardt disease...

AAVantgarde Bio (AAVantgarde), a clinical-stage, biotechnology company pioneering therapies for inherited retinal diseases (IRDs), has closed a US$141m Series B financing round. The round was co-led...

UK: Narayana Health expands global footprint with UK-based Practice Plus Group Hospitals

Narayana Health, an India-headquartered global healthcare provider, has moved into the UK healthcare market with the acquisition of Practice Plus Group Hospitals for a...

Germany: Tubulis announces second closing of Series C 

Tubulis has held the final close of its recently announced first close of its massive Series C at €344m (US$397m). The round welcomed additional new...

Switzerland: Oculis prices US$110m financing to accelerate development of Privosegtor

Oculis Holding, a listed global biopharmaceutical company focused on innovations to address unmet medical needs in ophthalmology and neuro-ophthalmology, has priced an oversubscribed US$110m...

US: Thermo Fisher Scientific to acquire Clario from Astorg, Nordic Capital, Novo Holdings and...

New York-listed Thermo Fisher Scientific, a world leader in life science and clinical research, is to acquire US-based Clario Holdings, a provider of endpoint...

Netherlands: Ottobock strengthens role as largest shareholder in Onward Medical following private placement

Euronext-listed Onward Medical, a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries, last week...
Advertisement